Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma

- Blank, Christian U., Lucas, Minke W., Pulleman, Saskia M., Gonzalez, Maria, Torres Acosta, Alejandro, van Houdt, Winan J., Lo, Serigne N., Kuijpers, Anke M. J., Spillane, Andrew, Klop, W. Martin C., Pennington, Thomas E., Zuur, Charlotte L., Scolyer, Richard A., Shannon, KF, Seinstra, BA, Rawson, RV, Haanen, JBAG, Ch'ng, S, Naipal, KAT, Stretch, J, van Thienen, JV, Rtshiladze, MA, Wilgenhof, S, van de Wiel, Bart A., Kapoor, R, Meerveld-Eggink, A, Grijpink-Ongering, LG, van Akkooi, ACJ, Reijers, ILM, Gyorki, DE, Grünhagen, DJ, Speetjens, FM, Vliek, SB, Placzke, J, Menzies, Alexander M., Spain, L, Stassen, RC, Amini-Adle, M, Lebbé, C, Faries, MB, Robert, C, Ascierto, PA, van Rijn, R, van den Berkmortel, FWPJ, Piersma, D, Lopez-Yurda, Marta, van der Westhuizen, Andre, Vreugdenhil, G, Aarts, MJB, Stevense-den Boer, MAM, Atkinson, V, Khattak, M, Andrews, MC, van den Eertwegh, AJM, Boers-Sonderen, MJ, Hospers, GAP, Hoeijmakers, Lotte L., Carlino, MS, de Groot, J-WB, Kapiteijn, E, Suijkerbuijk, KPM, Rutkowski, P, Sandhu, S, van der Veldt, AAM, Long, GV, Saw, Robyn P. M., Lijnsvelt, Judith M., Maher, Nigel G.

Adjuvant Therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)

- Weber, Jeffrey S., Schadendorf, Dirk, Ascierto, Paolo A., Sandhu, Shahneen, Eigentler, Thomas, Gutzmer, Ralf, Hassel, Jessica C., Robert, Caroline, Carlino, Matteo S., Di Giacomo, Anna Maria, Butler, Marcus O., Muñoz-Couselo, Eva, Del Vecchio, Michele, Brown, Michael P., Rutkowski, P, Haydon, A, Grob, J-J, Schachter, J, Queirolo, P, de la Cruz-Merino, L, van der Westhuizen, Andre, Menzies, AM, Re, S, Larkin, James, Bas, T, de Pril, V, Braverman, J, Tenney, DJ, Tang, H, Long, GV, Atkinson, Victoria, Schenker, Michael, Pigozzo, Jacopo, Gogas, Helen, Dalle, Stéphane, Meyer, Nicolas